Imagia is the indispensable AI healthcare partner for pharma, medical devices and clinical providers.
Imagia's mission is to leverage advances in artificial intelligence and accelerate the advent of accessible personalized medicine.The company's platform leverage advances in artificial intelligence to provide outcome-based structured clinical data and federated learning capabilities across multiple sources while preserving privacy, enabling clinicians to drive end-to-end discoveries of predictive, diagnostic, and prescriptive analytics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 24, 2019 | Series B | $22.70M | 1 | — | — | Detail |
Sep 9, 2015 | Seed | $5.68M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Desjardins-Innovatech | — | Series B |
Hacking Health Accelerator | — | Seed |